Nirvana Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023
For the six months, net loss was CAD 0.529369 million compared to CAD 0.549017 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.02 a year ago.